Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients

被引：0
|
作者：
Khamash, H. [1 ]
Mannon, R. [1 ]
Hanaway, M. [1 ]
Gaston, R. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1555
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Brueckner, A.
    Yanqui, E.
    Truong, C.
    Baliga, R.
    Bowman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 823 - 823
  • [2] Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction.
    Brueckner, A.
    Truong, C.
    Yanqui, E.
    Baliga, R.
    Bowman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 834 - 834
  • [3] EFFICACY AND SAFETY OF OUTPATIENT RABBIT-ANTITHYMOCYTE GLOBULIN INDUCTION IN DE-NOVO KIDNEY TRANSPLANT RECIPIENTS
    Sparkes, Tracy M.
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Sawinski, Deirdre
    MBloom, Roy D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 509 - 510
  • [4] Late-Onset Proteinuria After Antithymocyte Globulin Induction and De Novo Sirolimus Monotherapy in Kidney Transplant Recipients
    Thomusch, Oliver
    Tittelbach-Helmrich, Dietlind
    Seifert, Gabriel
    Pisarski, Przemyslaw
    TRANSPLANTATION, 2011, 92 (11) : E62 - E63
  • [5] Comparison of De Novo Sirolimus and Tacrolimus Based Immunosuppression in African American Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Duhart, B., Jr.
    Centeno, A.
    Krauss, A.
    Patel, S.
    Nezakatgoo, N.
    Eason, J.
    Rao, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 305 - 305
  • [6] Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
    Walter, K.
    Mincemoyer, L.
    Giang, J.
    Suero, J.
    Shah, N.
    Szempruch, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 689 - 690
  • [7] Assessment of Induction Antithymocyte Globulin Dose Reduction on Outcomes of De Novo Belatacept Immunosuppression in Kidney Transplant Recipients at Risk for Delayed Graft Function
    Ali, M.
    Wynd, M. A.
    Patel, A.
    Ahmed, V.
    Serur, D.
    Goldstein, M. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S849 - S850
  • [8] Alemtuzumab induction in kidney transplant recipients
    Nature Clinical Practice Nephrology, 2007, 3 (9): : 471 - 471
  • [9] Infectious Complications in Pediatric Renal Transplant Recipients Who Received Alemtuzumab or Rabbit Anti-Thymocyte Globulin Induction
    Doares, W.
    Chen, A.
    Lin, J. -J.
    Hart, L.
    Spainhour, L.
    Kaczmorski, S.
    Rogers, J.
    Stratta, R.
    Farney, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 440 - 441
  • [10] Safety and Efficacy of Condensed Induction Dosing of Rabbit Antithymocyte Globulin in Kidney Transplant Recipients
    Crowther, B.
    Sartain, E.
    Maffei, M.
    Nguyen, N.
    Klem, P.
    Lewis, V.
    Kaplan, B.
    Kennealey, P. T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S949 - S949
12345